News
Why Cohu Stock Is Sinking Today
Cohu (NASDAQ: COHU) stock is losing ground in Friday's daily trading session. The tech company's share price was down 7.2% as of 3:20 p.m. ET amid roughly flat trading for the S&P 500 and the Nasdaq
Healthcare REIT Posts 16.4% NOI Growth as Shares Soar 93%: Why This Fund's New Stake Stands Out
Neo Ivy Capital Management opened a new position in American Healthcare REIT (NYSE:AHR), according to its February 13, 2026, SEC filing, acquiring 136,925 shares in an estimated $6.44 million trade.
Should You Buy Garmin Stock Before Feb. 18?
Garmin (NYSE: GRMN) releases its fourth-quarter 2025 earnings report next Wednesday. If you're thinking about buying shares ahead of it, let me walk you through what's actually going on with this
Walker & Dunlop Stock Down 30% but Revenue Up 16%: Why This $6 Million Sale Stands Out
On February 13, 2026, First Sabrepoint Capital Management disclosed in an SEC filing that it sold 90,000 shares of Walker & Dunlop (NYSE:WD) for an estimated $6.39 million (based on quarterly
The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026
When you're looking to add growth to your portfolio, you may immediately think of technology stocks -- and this is a great idea. But technology stocks aren't the only players that may supercharge
Why Arista Networks Stock Is Soaring Today
Arista Networks (NYSE: ANET) stock is making big gains in Friday's trading. The networking-technology company's share price was up 5.4% as of 3 p.m. and had been up by as much as 10.1% earlier in
Laureate Education Stock Up 70% as Fund Trims $9 Million Stake Amid $1.7 Billion Revenue Outlook
First Sabrepoint Capital Management cut its stake in Laureate Education (NASDAQ:LAUR), selling 300,000 shares in Q4 2025 for an estimated $9.26 million based on quarterly average pricing, according
Should You Buy Palo Alto Networks Stock Before Earnings?
Palo Alto Networks (NASDAQ: PANW), one of the world's largest cybersecurity companies with more than 80,000 enterprise customers, will post its next earnings release on Feb. 17. Let's review its
Why This $14 Million Bet on Adtalem Global Stock Could Signal a Healthcare Education Pivot
On February 13, 2026, First Sabrepoint Capital Management LP disclosed a new position in Adtalem Global Education (NYSE:ATGE), acquiring 135,000 shares in an estimated $13.97 million trade.
Fund Opens $7.8 Million Position in Farmer Mac Despite 20% S&P Underperformance
On February 13, 2026, First Sabrepoint Capital Management LP disclosed a new position in Federal Agricultural Mortgage Corporation (NYSE:AGM), acquiring 44,500 shares with an estimated trade value
Don't Count Them Out Yet: Why International ETFs Could Still Outperform in 2026
I once worked with a seasoned investment advisor who liked to say that when American stocks zig, international stocks tend to zag. It sounds a bit simplistic, but in fact, there's a lot of truth to
Is Yelp Stock a Buy or Sell After the CEO Sold Shares Worth $1.7 Million?
Jeremy Stoppelman, Chief Executive Officer of Yelp (NYSE:YELP), executed a direct sale of 66,200 shares over Feb. 3 to Feb. 5, 2026, for total proceeds of approximately $1.7 million according to the
Ecovyst Stock Up 41% as One Fund's $20 Million Buy Creates 8% Portfolio Position
On February 13, 2026, Brightline Capital Management, LLC reported a new position in Ecovyst (NYSE:ECVT), initiating 2,050,000 shares with an estimated transaction value of $19.95 million.
According
Agnico Eagle (AEM) Earnings Call Transcript
Image source: The Motley Fool.
Friday, February 13, 2026 at 11 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
The Tech Sector Wall Street Is Shunning Right Now for All the Wrong Reasons
Tech stocks have been some of the biggest winners in the current bull market. That growth is primarily fueled by the advancing capabilities of artificial intelligence (AI), which holds the promise
Why Roku Stock Popped Today
Shares of Roku (NASDAQ: ROKU) rallied on Friday after the streaming platform's fourth-quarter earnings topped investors' expectations.
As of 2:25 p.m. EST, Roku's stock price was up more than 9%.
Got $1,000? 2 Top Growth Stocks to Buy That Could Double Your Money.
Buying fast-growing companies and holding their shares for the long run can help investors achieve market-beating returns. That's because growth stocks represent those companies capable of
Brightline Dumps $20 Million in Eos Energy Amid Staggering 117% Stock Surge
On February 13, 2026, Brightline Capital Management, LLC reported selling out its entire position in Eos Energy Enterprises (NASDAQ:EOSE), divesting 1,754,000 shares in a transaction estimated at
Enviri Stock Soars 110%, but What Should Investors Know About One Fund's $18 Million Exit?
On February 13, 2026, Brightline Capital Management, LLC disclosed it sold out its entire stake in Enviri (NYSE:NVRI), an estimated $17.77 million trade based on last-disclosed position values.
New $19 Million Bet Makes Kaiser Aluminum 8% of This Portfolio Amid a 102% Stock Surge
On February 13, 2026, Brightline Capital Management, LLC disclosed a new position in Kaiser Aluminum (NASDAQ:KALU), acquiring 168,000 shares worth an estimated $19.30 million.
According to a
Is Ralliant Stock a Buy After a Director Scooped Up 2,000 Shares?
Anelise Angelino Sacks, Director at Ralliant Corporation (NYSE:RAL), acquired 2,000 shares in an open-market purchase on Feb. 9, 2026, as reported in this SEC Form 4 filing.
Transaction value based
Impala Lifts The Buckle Stake to $21 Million as Retailer Posts $48.7 Million Quarterly Profit
On February 13, 2026, Impala Asset Management LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it bought 162,119 additional shares of The Buckle (NYSE:BKE), an estimated
Beyond Air XAIR Q3 2026 Earnings Call Transcript
Image source: The Motley Fool.
Friday, February 13, 2026 at 8 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss)
By all accounts its stock should be in the red today. CRISPR Therapeutics (NASDAQ: CRSP) only reported $864,000 in fourth-quarter revenue after Thursday's closing bell, leading to a loss of $1.37
Crypto Crash: Is Bitcoin Still the Best Cryptocurrency to Buy After This Sell-Off?
A crash is rarely a verdict on an asset's future. Frequently enough, it isn't even a verdict on much of anything other than how panicked some investors were at a specific period in time.
On that